Cholangiocarcinoma — evolving concepts and therapeutic strategies

Ilyas, Sumera I., Khan, Shahid A., Hallemeier, Christopher L., Kelley, Robin K., Gores, Gregory J.·2018·Nature Reviews Clinical Oncology

DOI 10.1038/nrclinonc.2017.157

Cited by (1,001)

Items 301–400 of 1,001

Piperlongumine induces autophagy in biliary cancer cells via�reactive oxygen species-activated Erk signaling pathway
San‐Yuan Chen, Hsin‐Yi Huang, Han‐Pei Lin, Chiung‐Yao Fang · 2019 · International Journal of Molecular Medicine
Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram
Yang Ge, Seogsong Jeong, Guijuan Luo, Yibin Ren, Baohua Zhang, Yongjie Zhang, Feng Shen, Qingbao Cheng, Chengjun Sui, Hongyang Wang et al. · 2020 · Hepatobiliary & pancreatic diseases international
Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting
Abdulsalam Alhalmi, Sarwar Beg, Kanchan Kohli, Md. Waris, Tanuja Singh · 2020 · Current Drug Targets
Association of prediabetes, diabetes, and diabetes duration with biliary tract cancer risk: A nationwide cohort study
Joo‐Hyun Park, Jung Yong Hong, Young Suk Park, Gunseog Kang, Kyungdo Han, Joon Oh Park · 2021 · Metabolism
A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
Zijian Zhang, Yun-peng Huang, Xiaoxue Li, Zhongtao Liu, Kai Liu, Xiaofeng Deng, Li Xiong, Heng Zou, Yu Wen · 2021 · Frontiers in Oncology
Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration
Bashir Lawal, Yu-Cheng Kuo, Sung‐Ling Tang, Feng‐Cheng Liu, Alexander T.H. Wu, Hung‐Yun Lin, Hsu‐Shan Huang · 2021 · Cells
Micro-RNA in Cholangiocarcinoma: Implications for Diagnosis, Prognosis, and Therapy
Anna Barbato, Fabiola Piscopo, Massimiliano Salati, Luca Reggiani Bonetti, Brunella Franco, Pietro Carotenuto · 2022 · Journal of Molecular Pathology
CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification
Shurui Zhou, Kege Yang, Shaojie Chen, Guoda Lian, Yuzhou Huang, Hanming Yao, Yue Zhao, Kaihong Huang, Dong Yin, Haoming Lin et al. · 2023 · Journal of Translational Medicine
New drug approvals for 2022: Synthesis and clinical applications
Shuo Yuan, Dandan Shen, Rui Jia, Ju‐Shan Sun, Jian Song, Hong‐Min Liu · 2023 · Medicinal Research Reviews
Natural Flavonoids Quercetin and Kaempferol Targeting G2/M Cell Cycle-Related Genes and Synergize with Smac Mimetic LCL-161 to Induce Necroptosis in Cholangiocarcinoma Cells
Thanpisit Lomphithak, Patthorn Jaikla, Apiwit Sae-Fung, Sasiprapa Sonkaew, Siriporn Jitkaew · 2023 · Nutrients
Curcumin enhances chemotherapeutic effects and suppresses ANGPTL4 in anoikis-resistant cholangiocarcinoma cells
Tin Tin San, Prasong Khaenam, Virapong Prachayasittikul, Banchob Sripa, Nawapol Kunkeaw, Waraporn Chan-on · 2020 · Heliyon
The Landmark Series: Intrahepatic Cholangiocarcinoma
Jordan M. Cloyd, Aslam M. Ejaz, Timothy Michael Pawlik · 2020 · Annals of Surgical Oncology
Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma
Jia-Yan Ni, Chao An, Tian-Qi Zhang, Zhimei Huang, Xiongying Jiang, Jin-Hua Huang · 2019 · International Journal of Hyperthermia
Emerging trends in modeling human liver disease in vitro
Gregory H. Underhill, Salman R. Khetani · 2019 · APL Bioengineering
Effect of postoperative early enteral nutrition on clinical outcomes and immune function of cholangiocarcinoma patients with malignant obstructive jaundice
Bingqiang Ma, Shiyong Chen, Zebin Jiang, Biao Wu, Yu He, Xinxin Wang, Yuan Li, Peng Gao, Xiaojun Yang · 2020 · World Journal of Gastroenterology
Diversity in cell differentiation, histology, phenotype and vasculature of mass‐forming intrahepatic cholangiocarcinomas
Hiep Nguyen Canh, Kenta Takahashi, Minako Yamamura, Zihan Li, Yasunori Sato, Kaori Yoshimura, Kazuto Kozaka, Minoru Tanaka, Yasuni Nakanuma, Kenichi Harada · 2021 · Histopathology
Anti-Glypican-1 Antibody–drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1–Positive Cholangiocarcinoma
Keiichiro Yokota, Satoshi Serada, Shigehiro Tsujii, Keisuke Toya, Tsuyoshi Takahashi, Takashi Matsunaga, Minoru Fujimoto, Sunao Uemura, Tsutomu Namikawa, Ichiro Murakami et al. · 2021 · Molecular Cancer Therapeutics
Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling
Yuke Shu, Qing Rong Xu, Yahong Xu, Qing Tao, Mingyang Shao, Xiaoyue Cao, Yuwei Chen, Zhenru Wu, Menglin Chen, Yongjie Zhou et al. · 2021 · Cell Death and Disease
Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
Liping Zhong, Yong Huang, Jian Guo He, Nuo Yang, Banghao Xu, Yun Ma, Junjie Liu, Chao Tang, Cheng‐Piao Luo, Pan Wu et al. · 2021 · Signal Transduction and Targeted Therapy
Gallbladder microbiota composition is associated with pancreaticobiliary and gallbladder cancer prognosis
Mari Kirishima, Seiya Yokoyama, Kei Matsuo, Taiji Hamada, Michiko Shimokawa, Toshiaki Akahane, Tomoyuki Sugimoto, Hirohito Tsurumaru, Matsujiro Ishibashi, Yuko Mataki et al. · 2022 · BMC Microbiology
Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery
Deyao Zhang, Huilan Zeng, Yangxun Pan, Yumo Zhao, Xin Wang, Jinbin Chen, Juncheng Wang, Yaojun Zhang, Zhongguo Zhou, Li Xu et al. · 2022 · Journal of Personalized Medicine
Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma
Min Peng, Hui Li, Huấn Cao, Yamei Huang, Weiping Yu, Chuanlai Shen, Jinyang Gu · 2023 · Journal of Gastroenterology
Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer
Hayato Nakagawa, Yuki Hayata, Tomoharu Yamada, Satoshi Kawamura, Nobumi Suzuki, Kazuhiko Koike · 2018 · International Journal of Molecular Sciences
Potential survival benefit of radiofrequency ablation for small solitary intrahepatic cholangiocarcinoma in nonsurgically managed patients: A population‐based analysis
Lu Yi Wu, Diamantis I. Tsilimigras, Ayesha Farooq, J. Madison Hyer, Katiuscha Merath, Anghela Z. Paredes, Rittal Mehta, Kota Sahara, Feng Shen, Timothy Michael Pawlik · 2019 · Journal of Surgical Oncology
Neoadjuvant chemoradiotherapy before resection of perihilar cholangiocarcinoma: A systematic review
Minas Baltatzis, Santhalingam Jegatheeswaran, Ajith Kumar Siriwardena · 2020 · Hepatobiliary & pancreatic diseases international
Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018–2023
Donghee Kim, Richie Manikat, Karn Wijarnpreecha, George T. Cholankeril, Aijaz Ahmed · 2024 · Clinical and Molecular Hepatology
Organoids and spheroids: advanced in vitro models for liver cancer research
Mirella Pastore, Alessia Giachi, Elena Spínola-Lasso, Fabio Marra, Chiara Raggi · 2025 · Frontiers in Cell and Developmental Biology
Simvastatin overcomes the pPCK1‐pLDHA‐SPRINGlac axis‐mediated ferroptosis and chemo‐immunotherapy resistance in AKT‐hyperactivated intrahepatic cholangiocarcinoma
Jinghan Zhu, Yixiao Xiong, Yuxin Zhang, Huifang Liang, Kun Cheng, Yuanxiang Lu, Guangzhen Cai, Yang Feng Wu, Yunhui Fan, Xiaoping Chen et al. · 2025 · 癌症：英文版
Liver and Pancreas: Do Similar Embryonic Development and Tissue Organization Lead to Similar Mechanisms of Tumorigenesis?
Elsa Ghurburrun, Ivan Borbath, Frédéric P. Lemaigre, Patrick Jacquemin · 2018 · Gene Expression
Animal models of cholangiocarcinoma: What they teach us about the human disease
Massimiliano Cadamuro, Simone Brivio, Tommaso Stecca, Eleanna Kaffe, Valeria Mariotti, Chiara Milani, Romina Fiorotto, Carlo Spirlı̀, Mario Strazzabosco, Luca Fabris · 2018 · Clinics and Research in Hepatology and Gastroenterology
Assessment of Liver Function for Evaluation of Long-Term Outcomes of Intrahepatic Cholangiocarcinoma: A Multi-Institutional Analysis of 620 Patients
Hui Li, Jiaxin Li, Jinju Wang, Hailing Liu, Bole Cai, Genshu Wang, Hong Mei Wu · 2020 · Frontiers in Oncology
Circular RNA Circ0021205 Promotes Cholangiocarcinoma Progression Through MiR-204-5p/RAB22A Axis
Jianfei Tu, Weiqian Chen, Liyun Zheng, Shiji Fang, Dengke Zhang, Chunli Kong, Yang Yang, Rongfang Qiu, Zhongwei Zhao, Chenying Lu et al. · 2021 · Frontiers in Cell and Developmental Biology
Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway
Huayuan Liu, Caiyun Liu, Mengya Wang, Dongxu Sun, Pengcheng Zhu, Ping Zhang, Xueying Tan, Guangjun Shi · 2021 · Scientific Reports
Laparoscopic versus open surgery for hilar cholangiocarcinoma: a retrospective cohort study on short-term and long-term outcomes
Delin Ma, Wei Wang, Jianlei Wang, Tingxiao Zhang, Zhaochen Jiang, Gang Du, Jinhuan Yang, Xiqing Zhang, Guanjun Qin, Bin Jin · 2021 · Surgical Endoscopy
Safety and initial efficacy of ablative radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma
Ricardo Paz‐Fumagalli, Jacob M. Core, Carlos A. Padula, Seyed Ali Montazeri, J. Mark McKinney, Gregory T. Frey, Zlatko Devcic, Andrew R. Lewis, Charles A. Ritchie, Kabir Mody et al. · 2021 · Oncotarget
TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF‐κB‐inducing kinase–mediated hepatocyte transdifferentiation
Yuto Shiode, Takahiro Kodama, Satoshi Shigeno, Kazuhiro Murai, Satoshi Tanaka, Justin Y. Newberg, Jumpei Kondo, Shogo Kobayashi, Ryoko Yamada, Hayato Hikita et al. · 2022 · Hepatology
The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma
Orawan Suppramote, Sunisa Prasopporn, Satinee Aroonpruksakul, Ben Ponvilawan, Jiradej Makjaroen, Monthira Suntiparpluacha, Krittiya Korphaisarn, Komgrid Charngkaew, Rawisak Chanwat, Trairak Pisitkun et al. · 2022 · Frontiers in Oncology
Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma
Lulu Xie, Jingzheng Huang, Linling Wang, Wenrui Ren, Hao Tian, Anhong Hu, Jun Liang, Yuqing Jiao, Yali Li, Qunfang Zhou et al. · 2022 · Frontiers in Pharmacology
Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
Qiang Feng, Baozhen Sun, Tianyi Xue, Rong Li, Chao Lin, Yongjian Gao, Liqun Sun, Yue Zhuo, Dongxu Wang · 2022 · Frontiers in Immunology
Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment
Anda Shi, Zengli Liu, Zhongqi Fan, Kangshuai Li, Xingkai Liu, Yongchang Tang, Jiaming Hu, Xingyong Li, Lizhuang Shu, Liming Zhao et al. · 2024 · Gut
Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma
Mengge Li, Min Du, Hui Cong, Yuanyuan Gu, Yuan Fang, Jin Li, Yu Gan, Hong Tu, Jinyang Gu, Qiang Xia · 2020 · Hepatology Research
HOTTIP Enhances Gemcitabine and Cisplatin Resistance Through Sponging miR-637 in Cholangiocarcinoma
Kun Gao, Shuhua Chen, Xiangyu Yang · 2021 · Frontiers in Oncology
Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining
Zhengguang Wang, Yaqi Du · 2021 · International Immunopharmacology
Deep Learning Radiomics to Predict Regional Lymph Node Staging for Hilar Cholangiocarcinoma
Yubizhuo Wang, Jiayuan Shao, Pan Wang, Lintao Chen, Mingliang Ying, Siyuan Chai, Shijian Ruan, Wuwei Tian, Yongna Cheng, Hongbin Zhang et al. · 2021 · Frontiers in Oncology
Newest Therapies for Cholangiocarcinoma: An Updated Overview of Approved Treatments with Transplant Oncology Vision
Yuqi Zhang, Abdullah Esmail, Vincenzo Mazzaferro, Maen Abdelrahim · 2022 · Cancers
Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity
Fumimasa Tomooka, Kosuke Kaji, Norihisa Nishimura, Takahiro Kubo, Satoshi Iwai, Akihiko Shibamoto, Junya Suzuki, Koh Kitagawa, Tadashi Namisaki, Takemi Akahane et al. · 2023 · Cells
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma
Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko, Aaron Stahl, Yvonne Rasen, Christine Geisler, Kristina Ruhm, Marion Klaumuenzer, Thales Kronenberger, Stefan Laufer et al. · 2024 · Nature Communications
Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival
Sri Harsha Tella, Anuhya Kommalapati, Siddhartha Yadav, John R. Bergquist, Gaurav Goyal, Lori M. Durgin, Mitesh J. Borad, Sean Patrick Cleary, Mark Joseph Truty, Amit Mahipal · 2020 · European Journal of Surgical Oncology
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
Sven Heiko Loosen, Annemarie Breuer, Frank Tacke, Jakob Nikolas Kather, Joao Gorgulho, Patrick H. Alizai, Jan Bednarsch, Anjali A. Roeth, Georg Lurje, Sophia M. Schmitz et al. · 2020 · JHEP Reports
Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma
Bao‐Ye Sun, Zhu-Tao Wang, Ke-Zhu Chen, Yang Song, Jing-Fang Wu, Dai Zhang, Guo-Qiang Sun, Jian Zhou, Jia Fan, Bo Hu et al. · 2024 · Cell Death Discovery
ACSL3 is an unfavorable prognostic marker in cholangiocarcinoma patients and confers ferroptosis resistance in cholangiocarcinoma cells
Apiwit Sae-Fung, Nawaporn Vinayavekhin, Bengt Fadeel, Siriporn Jitkaew · 2024 · npj Precision Oncology
Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells
Koh Kitagawa, Kei Moriya, Kosuke Kaji, Soichiro Saikawa, Shinya Sato, Norihisa Nishimura, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji · 2020 · International Journal of Molecular Sciences
Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
Suthida Panwong, Methi Wathikthinnakon, Thida Kaewkod, Nunghathai Sawasdee, Yingmanee Tragoolpua, Pa‐thai Yenchitsomanus, Aussara Panya · 2021 · Molecules
Exosomes in the tumor microenvironment of cholangiocarcinoma: current status and future perspectives
Kai Zhao, Xiangyu Li, Yuanxin Shi, Yun Lü, Qiu Peng, Zhengdong Deng, Wei Yao, Jianming Wang · 2022 · Journal of Translational Medicine
Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone? An updated meta-analysis of nineteen trials
Shaoming Song, Haojie Jin, Qinghao Cheng, Shiyi Gong, Kun Lv, Ting Lei, Hongwei Tian, Xiaofei Li, Caining Lei, Wenwen Yang et al. · 2022 · Surgical Endoscopy
Clinical impact of a novel device delivery system in the diagnosis of bile duct lesions: A single‐center experience
Tomoaki Matsumori, Norimitsu Uza, Masahiro Shiokawa, Takahisa Maruno, Yoshihiro Nishikawa, Toshihiro Morita, Takeshi Kuwada, Saiko Marui, Hirokazu Okada, Kojiro Taura et al. · 2022 · Journal of Gastroenterology and Hepatology
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives
Lucia Cerrito, Maria Elena Ainora, Raffaele Borriello, Giulia Piccirilli, Matteo Garcovich, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco · 2023 · Cancers
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version)
Han Wang, Jun Chen, Xin Zhang, Xia Sheng, Xiaoyan Chang, Jie Chen, Minshan Chen, Hui Fen Dong, Guangjie Duan, He-Ping Hu et al. · 2023 · Journal of Clinical and Translational Hepatology
Advances in the Early Detection of Hepatobiliary Cancers
Hasan Çağrı Yıldırım, Gözde Kavgacı, Elvin Chalabiyev, Ömer Dızdar · 2023 · Cancers
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical–Radiomic Model
Francesco Fiz, Noemi Rossi, Serena Langella, Andrea Ruzzenente, Matteo Serenari, Francesco Ardito, Alessandro Cucchetti, Teresa Gallo, Giulia Zamboni, Cristina Mosconi et al. · 2023 · Cancers
HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis
Shuoshuo Ma, Yang Ma, Feiyu Qi, Jiasheng Lei, Fangfang Chen, Wanliang Sun, Dongdong Wang, Shuo Zhou, Zhong Liu, Zheng Lu et al. · 2023 · World Journal of Surgical Oncology
Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis
Francesca Saffioti, Vasileios K. Mavroeidis · 2021 · World Journal of Gastrointestinal Oncology
Differential of cholangiocarcinoma disease using Raman spectroscopy combined with multivariate analysis
Joanna Depciuch, Magdalena Parlińska‐Wojtan, Kursat Rahmi Serin, Huri Bulut, Engı̇n Ulukaya, Nevzat Tarhan, Zozan Güleken · 2022 · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes
Jinqiang Zhang, Weina Chen, Wenbo Ma, Chang Han, Kyoungsub Song, Hyunjoo Kwon, Tong Wu · 2022 · American Journal Of Pathology
In vivo detection of bile duct pre-cancer with endoscopic light scattering spectroscopy
Douglas K. Pleskow, Mandeep Sawhney, Paul Kumar Upputuri, Tyler M. Berzin, Mark F. Coughlan, Umar Khan, Maria Glyavina, Xuejun Zhang, Liming Chen, Conor J. Sheil et al. · 2023 · Nature Communications
An overview of extrahepatic cholangiocarcinoma: from here to where?
Yongheng Yang, Xiaolu Zhang · 2023 · Frontiers in Oncology
Surufatinib combined with photodynamic therapy induces ferroptosis to inhibit cholangiocarcinoma in vitro and in tumor models
Yun-peng Huang, Yongxiang Wang, Hui Zhou, Zhong-Tao Liu, Zijian Zhang, Li Xiong, Heng Zou, Yu Wen · 2024 · Frontiers in Pharmacology
The cyclin‑dependent kinase pathway involving CDK1 is a potential therapeutic target for cholangiocarcinoma
Minako Yamamura, Yasunori Sato, Kenta Takahashi, Motoko Sasaki, Kenichi Harada · 2019 · Oncology Reports
Upregulated microRNA‐194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2
Jun Gao, Chao Dai, Xin Yu, Xiangbao Yin, Fan Zhou · 2020 · Journal of Cellular Biochemistry
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
Johannes Byrling, Theresa Kristl, Dingyuan Hu, Indira Plá, Aniel Sánchez, Agata Sasor, Roland E. Andersson, György Marko‐Varga, Bodil Andersson · 2020 · Journal of Translational Medicine
A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis
Beihui Xue, Sunjie Wu, Mingyue Zhang, Junjie Hong, Bole Liu, Nina Xu, Qiqiang Zeng, Kun Tang, Xiangwu Zheng · 2021 · Abdominal Radiology
Comprehensive Immunogenomic Profiling of IDH1- / 2 -Altered Cholangiocarcinoma
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, Lawrence N. Kwong, Zeyad Abouelfetouh, Anaemy Danner De Armas, Lianchun Xiao, Karthikeyan Murugesan, Natalie A. Danziger, Dean C. Pavlick et al. · 2024 · JCO Precision Oncology
FOLFIRI as second-line treatment of metastatic biliary tract cancer patients
Rafael Caparica, Adrien Lengelé, Winnie Tatiana Bekolo Nga, Alain Hendlisz · 2019 · Autopsy and Case Reports
Targeting the FGFR signaling pathway in cholangiocarcinoma: promise or delusion?
Jing Wang, Xiaokang Xing, Qijun Li, Ge Zhang, Tao Wang, Hongming Pan, Da Li · 2020 · Therapeutic Advances in Medical Oncology
The long noncoding RNA DLGAP1‐AS2 facilitates cholangiocarcinoma progression via miR‐505 and GALNT10
Zhao Liu, Lili Pan, Xiaofang Yan, Xiu-Na Duan · 2020 · FEBS Open Bio
Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2–Platelet‐Derived Growth Factor Receptor Beta–Yes‐Associated Protein Signaling Axis
Xin Luo, Nellie A. Campbell, Li He, Daniel R. O’Brien, Mark S. Singer, Hassan Lemjabbar‐Alaoui, Keun Soo Ahn, Rory L. Smoot, Michael S Torbenson, Steven D. Rosen et al. · 2021 · Hepatology
Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma
Peng Liao, Li Cao, Hang Chen, Shui-Zi Pang · 2021 · Medicine
Liver Resection for Intrahepatic Cholangiocarcinoma—Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year Period
Hauke Lang, Janine Baumgart, Stefan Heinrich, Tobias Huber, Lisa-Katharina Heuft, Rabea Margies, Jens Mittler, Felix Hähn, Tiemo Sven Gerber, Friedrich Foerster et al. · 2021 · Journal of Clinical Medicine
Hydroxychloroquine Induces Apoptosis in Cholangiocarcinoma via Reactive Oxygen Species Accumulation Induced by Autophagy Inhibition
Jiaqi Chen, Qiaoya Pan, Yang Bai, Xuepeng Chen, Yi Zhou · 2021 · Frontiers in Molecular Biosciences
Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific Smad4/Pten mutant mice
Ming Zhao, Yingyao Quan, Jianming Zeng, Xueying Lyu, Haitao Wang, Josh Haipeng Lei, Yangyang Feng, Jun Xu, Qiang Chen, Heng Sun et al. · 2021 · International Journal of Biological Sciences
Comparing palliative treatment options for cholangiocarcinoma: photodynamic therapy vs. radiofrequency ablation
Tayyaba F. Mohammad, Michel Kahaleh · 2022 · Clinical Endoscopy
The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma
Isabella Lurje, Zoltán Czigány, Sarah Eischet, Jan Bednarsch, Tom Florian Ulmer, Peter Isfort, Pavel Strnad, Christian Trautwein, Frank Tacke, Ulf P. Neumann et al. · 2022 · Hepatology Communications
mRNA Vaccine - A New Cancer Treatment Strategy
Tian Tan, Shuting Deng, Bing-Huo Wu, Qi Yang, Mengwan Wu, Hong Wu, Chenhui Cao, Chuan Shan Xu · 2023 · Current Cancer Drug Targets
Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells
Ekapot Singsuksawat, Chanitra Thuwajit, Komgrid Charngkaew, Peti Thuwajit · 2018 · Cancer Cell International
Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas
Ville J. Sallinen, Jukka Sirén, Heikki Mäkisalo, T. E. Lehtimäki, Eila Lantto, Arto Kokkola, Arno J. Nordin · 2019 · Scandinavian Journal of Surgery
Current status of laparoscopic radical hilar cholangiocarcinoma in Mainland China
Yizhen Chen, Youyao Xu, Yuhua Zhang · 2020 · BioScience Trends
Systemic treatment options for advanced biliary tract carcinoma
Changqing Xie, Nicole McGrath, Cecilia Monge Bonilla, Jianyang Fu · 2020 · Journal of Gastroenterology
Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis
Zengtao Hu, Lining Huang, Weina Wang, Canghai Guan, Yuqiao Zhao, Lang Liu, Xingming Jiang · 2021 · Digestive Diseases and Sciences
MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs
Renjie Yang, Dong Wang, Shen Han, Yichao Gu, Zhi Li, Lei Hong Deng, Aihong Yin, Yun Gao, Xiangcheng Li, Yue Yu et al. · 2021 · International Journal of Biological Sciences
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma
Weiren Liu, Huqiang Wang, Qianfu Zhao, Chenyang Tao, Wei‐Feng Qu, Yushan Hou, Run Huang, Zimei Sun, Gui‐Qi Zhu, Xi‐Fei Jiang et al. · 2023 · 癌症：英文版
Intrahepatic cholangiocarcinoma: Insights on molecular testing, targeted therapies, and future directions from a multidisciplinary panel
R. Gujarathi, S. Peshin, Xu-Chen Zhang, Melinda Bachini, M. Meeks, R. Shroff, Anjana Pillai · 2025 · Hepatology Communications
Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
Hong Yan Wu, Yulong Wei, Mei Jian, Hong Lu, Qingzhu Song, Liheng Hao, Yong Yue · 2021 · OncoTargets and Therapy
Immunotherapy in cholangiocarcinoma: From concept to clinical trials
Wenyan Yao, Wei Gong · 2021 · Surgery in Practice and Science
Endoscopic radiofrequency ablation for malignant biliary obstruction
Jana Jarošová, Peter Mačinga, Alzbeta Hujova, Jan Král, Ondřej Urban, Julius Špičák, Tomáš Hucl · 2021 · World Journal of Gastrointestinal Oncology
TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
Chunguang Guo, Zaoqu Liu, Yin Yu, Yunfang Chen, Hui Liu, Yaming Guo, Zhenyu Peng, Gaopo Cai, Zhaohui Hua, Xinwei Han et al. · 2022 · Frontiers in Genetics
Light-to-Moderate Alcohol Consumption Increases the Risk of Biliary Tract Cancer in Prediabetes and Diabetes, but Not in Normoglycemic Status: A Nationwide Cohort Study
Joo‐Hyun Park, Jung Yong Hong, Kyungdo Han, Young Suk Park, Joon Oh Park · 2022 · Journal of Clinical Oncology
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma
Lavinia Patricia Mocan, Rareș Crăciun, Cristiana Maria Grapa, Carmen Stanca Melincovici, Ioana Rusu, Nadim Al Hajjar, Zeno Adrian Sparchez, Daniel‐Corneliu Leucuta, Maria Ilies, Mihaela Spârchez et al. · 2022 · Cancer Immunology Immunotherapy
The clinicopathological significance and relapse predictive role of tumor microenvironment of intrahepatic cholangiocarcinoma after radical surgery
Yiling Zheng, Ning Huang, Shuwen Kuang, Jing Zhang, Hong Zhao, Jianxiong Wu, Mei Liu, Liming Wang · 2022 · Cancer
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma
Bao‐Ye Sun, Zhangfu Yang, Zhu-Tao Wang, Gao Liu, Cheng Zhou, Jian Zhou, Jia Fan, Wei Gan, Yong Yi, Shuang‐Jian Qiu · 2023 · World Journal of Surgical Oncology
A Systematic Review and Meta-Analysis: Volatile Organic Compound Analysis in the Detection of Hepatobiliary and Pancreatic Cancers
Melina Pelling, Subashini Chandrapalan, Emily S. West, Ramesh Pulendran Arasaradnam · 2023 · Cancers